Otero-Romero S, Ramió-Torrentà Ll, Pericot I, Carmona O, Perkal H, Saiz A, Bufill E, Robles R, Simón E, Llufriu S, Vaqué-Rafart J, Sastre-Garriga J, Montalban X
Multiple Sclerosis Centre of Catalonia (Cemcat), Department of Neurology-Neuroimmunology, Vall d'Hebron University Hospital, Barcelona, Spain; Preventive Medicine and Epidemiology Department, Vall d'Hebron University Hospital, Barcelona, Spain.
Neuroimmunology and Multiple Sclerosis Unit, Department of Neurology, Dr. Josep Trueta University Hospital, Neurodegeneration and Neuroinflammation Group, Girona Biomedical Research Institute (IDIBGI), Girona, Spain.
J Neurol Sci. 2015 Dec 15;359(1-2):146-50. doi: 10.1016/j.jns.2015.10.042. Epub 2015 Oct 28.
Recent studies show an increasing incidence of multiple sclerosis (MS) in southern Europe. Although by its geographical location and genetic characteristics Spain is expected to be similar to other southern European regions, data on incidence are scarce. The aim of this study was to determine the onset-adjusted incidence of MS in the Girona province in Catalonia (Spain).
A prospective incidence study pooling data from the population-based Catalonia MS Registry was performed. Incident cases were defined as patients who had the onset of symptoms compatible with a clinically isolated syndrome (CIS) suggestive of MS in 2009 and fulfilled McDonald-2005 criteria during follow-up. Age- and sex-specific incidence rates were obtained.
The Registry included 182 patients residing in Girona that presented a CIS from January 2009 to December 2013. Fifty one patients had the onset of symptoms in 2009, of whom 27 patients fulfilled the diagnostic criteria, giving an incidence of 3.6 per 100,000 (CI 95% 2.4-5.3) inhabitants; 4.3 (CI 95% 2.5-7.1) for women and 2.9 (CI 95% 1.4-5.2) for men. The age-adjusted incidence rate for the European population was 3.29 (CI 95% 3.2-3.3).
The incidence estimation derived in this study is consistent with recent epidemiological data of MS in southern Europe suggesting an increase in incidence in this region.
近期研究表明,多发性硬化症(MS)在南欧的发病率呈上升趋势。尽管从地理位置和基因特征来看,西班牙预计与其他南欧地区相似,但关于发病率的数据却很匮乏。本研究的目的是确定西班牙加泰罗尼亚自治区赫罗纳省MS的发病调整发病率。
进行了一项前瞻性发病率研究,汇总了基于人群的加泰罗尼亚MS登记处的数据。发病病例定义为在2009年出现符合临床孤立综合征(CIS)且提示MS的症状,并在随访期间符合2005年麦克唐纳标准的患者。获得了特定年龄和性别的发病率。
该登记处纳入了2009年1月至2013年12月期间居住在赫罗纳且出现CIS的182名患者。2009年有51名患者出现症状,其中27名患者符合诊断标准,发病率为每10万居民3.6例(95%可信区间2.4 - 5.3);女性为4.3例(95%可信区间2.5 - 7.1),男性为2.9例(95%可信区间1.4 - 5.2)。欧洲人群的年龄调整发病率为3.29(95%可信区间3.2 - 3.3)。
本研究得出的发病率估计与南欧MS的近期流行病学数据一致,表明该地区发病率有所上升。